홈 카테고리 맞춤형시장조사 국제컨퍼런스 글로벌 파트너 메일링 서비스 회사소개회사소개 Contact Us
English Japaness Chinese
Home > 시장보고서 > 파머슈티컬 > 당뇨병 > European Diabetes Market
카테고리
파머슈티컬 (4931)
감염질환 (349)
골질환 치료 (38)
당뇨병 (194)
백신 (181)
비만치료/다이어트 (44)
비처방 의약품 (152)
수의학 (17)
신경질환 (174)
신약개발 (1529)
암치료 (941)
약물전달 (185)
의약품 규제환경 (127)
정신질환 (86)
제네릭 의약품 (128)
제약회사분석 (523)
처방약 (165)
시장보고서

European Diabetes Market

리서치사 Frost & Sullivan
발행일 2006년 07월 상품코드 44980
페이지 정보
가격
US $ 6,500 ￦ 7,744,700 Web Access (Regional License)
US $ 7,000 ￦ 8,340,500 Hard Copy & Web Access (Regional License)


영문목차

Abstract

This Frost & Sullivan research service titled European Diabetes Market provides an overview of current treatment options, drugs in pipeline, technological advancements in diabetes and revenues of the current delivery methods. The study also offers a complete analysis of key market drivers, restraints, and trends prevailing in the European market. In this research, Frost & Sullivan's expert analysts thoroughly examine the markets for insulin and OAD drugs.

Table of Contents

  • 1. Executive Summary
    • 1. Overview
      • 1. Executive Summary of the European Diabetes Market
  • 2. Introduction
    • 1. Disease State Overview
      • 1. Epidemiology
    • 2. Research Methodology
      • 1. Research Methodology for the European Diabetes Market
      • 2. Assumptions and Limitations
  • 3. Industry Challenges
    • 1. Challenges and Issues
      • 1. Challenges Facing the European Diabetes Market
  • 4. European Diabetes Market Analysis
    • 1. Total European Diabetes Market
      • 1. Market Overview and Segmentation
      • 2. Revenue Forecasts
    • 2. Insulin Market
      • 1. Market Overview
      • 2. Trends by Segment
      • 3. Market Engineering Measurements
      • 4. Market Drivers
      • a. Increasing Diabetic Population Puts More Pressure on Governments to Reduce Costs Incurred Because of Complications
      • b. Awareness of the Importance of Tight Glycaemic Control
      • c. Acceptance of Insulin Therapy among the Type 2 Diabetic Population
      • d. Introduction of More Convenient Forms of Insulin Delivery
      • 5. Market Restraints
      • a. Cost of Insulin Therapy
      • b. Resistance to Insulin Therapy
      • 6. Impact Probability Analysis
      • 7. Competitive Structure
      • 8. Market Share Analysis
      • 9. Revenue Forecasts
    • 3. Oral Anti-Diabetic (OAD) Drugs Market
      • 1. Market Overview
      • 2. Trends by Segment
      • 3. Market Engineering Measurements
      • 4. Market Drivers
      • 5. Market Restraints
      • 6. Impact Probability Analysis
      • 7. Competitive Structure
      • 8. Revenue Forecasts
    • 4. Diabetes Drugs in Pipeline
      • 1. Pipeline Analysis
  • 5. German Diabetes Market
    • 1. Market Engineering Research
      • 1. Market Overview
      • 2. Market Engineering Measurements
      • 3. Revenue Forecasts
  • 6. The United Kingdom Diabetes Market
    • 1. Market Engineering Research
      • 1. Market Overview
      • 2. Market Engineering Measurements
      • 3. Revenue Forecasts
  • 7. French Diabetes Market
    • 1. Market Engineering Research
      • 1. Market Overview
      • 2. Market Engineering Measurements
      • 3. Revenue Forecasts
  • 8. Italian Diabetes Market
    • 1. Market Engineering Research
      • 1. Market Overview
      • 2. Market Engineering Measurements
      • 3. Revenue Forecasts
  • 9. Spanish Diabetes Market
    • 1. Market Engineering Research
      • 1. Market Overview
      • 2. Market Engineering Measurements
      • 3. Revenue Forecasts
  • 10. Scandinavian Diabetes Market
    • 1. Market Engineering Research
      • 1. Market Overview
      • 2. Market Engineering Measurements
      • 3. Revenue Forecasts
  • 11. Benelux Diabetes Market
    • 1. Market Engineering Research
      • 1. Market Overview
      • 2. Market Engineering Measurements
      • 3. Revenue Forecasts
  • 12. Strategic Recommendations
    • 1. Market Engineering Recommendations
      • 1. Strategic Recommendations for the European Diabetes Market
  • 13. Database of Key Industry Participants
    • 1. Key Industry Participants
      • 1. Major Participants
  • 15. Appendix
    • 1. Decision Support Database
      • 1. Diabetes Incidence
      • 2. Diabetes Prevalence
      • 3. Diabetes Prevalence Percent
      • 4. Obesity Prevalence
      • 5. Total Healthcare Expenditure
Back to Top